Knowles MA - Search Results

1

Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma.

Conway C, Beswick S, Elliott F, Chang YM, Randerson-Moor J, Harland M, Affleck P, Marsden J, Sanders DS, Boon A, Knowles MA, Bishop DT, Newton-Bishop JA. Conway C, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 2010 May;49(5):425-38. doi: 10.1002/gcc.20753. Genes Chromosomes Cancer. 2010. PMID: 20140953 Free PMC article.

2

The spectrum of TP53 mutations in bladder carcinoma.

Williamson MP, Elder PA, Knowles MA. Williamson MP, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 1994 Feb;9(2):108-18. doi: 10.1002/gcc.2870090206. Genes Chromosomes Cancer. 1994. PMID: 7513540

3

Deletion mapping of chromosome 11 in carcinoma of the bladder.

Shaw ME, Knowles MA. Shaw ME, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 1995 May;13(1):1-8. doi: 10.1002/gcc.2870130102. Genes Chromosomes Cancer. 1995. PMID: 7541638

4

Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.

Bell SM, Zuo J, Myers RM, Knowles MA. Bell SM, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 1996 Oct;17(2):108-17. doi: 10.1002/(SICI)1098-2264(199610)17:2<108::AID-GCC6>3.0.CO;2-9. Genes Chromosomes Cancer. 1996. PMID: 8913728

5

Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.

Nishiyama H, Takahashi T, Kakehi Y, Habuchi T, Knowles MA. Nishiyama H, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 1999 Oct;26(2):171-5. Genes Chromosomes Cancer. 1999. PMID: 10469456

6

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.

Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT. Randerson-Moor JA, et al. Hum Mol Genet. 2001 Jan 1;10(1):55-62. doi: 10.1093/hmg/10.1.55. Hum Mol Genet. 2001. PMID: 11136714

7

Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines.

Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA. Williams SV, et al. Among authors: knowles ma. Genes Chromosomes Cancer. 2002 May;34(1):86-96. doi: 10.1002/gcc.10050. Genes Chromosomes Cancer. 2002. PMID: 11921286

8

Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.

Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D. Knowles MA, et al. Cancer Res. 2003 Nov 15;63(22):7652-6. Cancer Res. 2003. PMID: 14633685

9

High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.

Natrajan R, Louhelainen J, Williams S, Laye J, Knowles MA. Natrajan R, et al. Among authors: knowles ma. Cancer Res. 2003 Nov 15;63(22):7657-62. Cancer Res. 2003. PMID: 14633686

10

Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification.

Aveyard JS, Knowles MA. Aveyard JS, et al. Among authors: knowles ma. J Mol Diagn. 2004 Nov;6(4):356-65. doi: 10.1016/S1525-1578(10)60532-6. J Mol Diagn. 2004. PMID: 15507675 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters